Sangeeta Mehta1, John Granton2, Anthony C Gordon3, Deborah J Cook4, Stephen Lapinsky5, Gary Newton6, Kris Bandayrel5, Anjuli Little5, Chuin Siau7, Dieter Ayers8, Joel Singer8, Terry C K Lee8, Keith R Walley9, Michelle Storms9, D James Cooper10, Cheryl L Holmes11, Paul Hebert12, Jeffrey Presneill13, James A Russell9. 1. Department of Medicine and Interdepartmental Division of Critical Care Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada. smehta@mtsinai.on.ca. 2. University Health Network-General Division, University of Toronto, Toronto, Ontario, Canada. 3. Intensive Care, Charing Cross Hospital, Imperial, College, London, UK. 4. Departments of Medicine, Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada. 5. Department of Medicine and Interdepartmental Division of Critical Care Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada. 6. Department of Medicine and Division of Cardiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada. 7. Department of Respiratory Medicine, Changi General Hospital, Singapore, Singapore. 8. School of Population and Public Health, Centre for Health Evaluation and Outcome Sciences, and University of British Columbia, Vancouver, British Columbia, Canada. 9. Critical Care Research, Laboratories, Heart and Lung Institute, St. Paul's Hospital, and University of British Columbia, Vancouver, British Columbia, Canada. 10. Alfred Hospital, Monash University, Melbourne, Australia. 11. Kelowna General Hospital, Kelowna, and University of British Columbia, Kelowna, British Columbia, Canada. 12. Ottawa Hospital-General Campus, and University of Ottawa, Ottawa, Ontario, Canada. 13. Mater Health Services, University of Queensland and Monash University, South Brisbane, Queensland, Australia.
Unfortunately this article [1] published without its additional files (Additional files 1, 2, 3, 4, 5, 6 and 7). Please see these listed below and attached as additional files to this erratum.Participating sites. (DOCX 13 kb)Baseline characteristics and outcomes in vasopressin and norepinephrine-treated patients, grouped by serum troponin levels. (DOCX 17 kb)Specific ECG diagnoses and patient outcomes. (DOCX 14 kb)Outcomes related to ECG ischemia for all patients and for patients with troponin elevation. (DOCX 15 kb)Comparison of mean arterial pressure and heart rate in the norepinephrine group and vasopressin group. (DOCX 122 kb)Rates of total norepinephrine infusion (open-label and study drug) in the vasopressin treated group and the norepinephrine treated group. (DOCX 60 kb)Serum creatinine in the vasopressin treated group and the norepinephrine treated group. (DOCX 64 kb)
Authors: Sangeeta Mehta; John Granton; Anthony C Gordon; Deborah J Cook; Stephen Lapinsky; Gary Newton; Kris Bandayrel; Anjuli Little; Chuin Siau; Dieter Ayers; Joel Singer; Terry C K Lee; Keith R Walley; Michelle Storms; D James Cooper; Cheryl L Holmes; Paul Hebert; Jeffrey Presneill; James A Russell Journal: Crit Care Date: 2013-06-20 Impact factor: 9.097